{
    "Symbol": "ABBV",
    "AssetType": "Common Stock",
    "Name": "AbbVie Inc",
    "Description": "AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories.",
    "CIK": "1551152",
    "Exchange": "NYSE",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "PHARMACEUTICAL PREPARATIONS",
    "Address": "1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL, US",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-06-30",
    "MarketCapitalization": "335003189000",
    "EBITDA": "26249001000",
    "PERatio": "63.24",
    "PEGRatio": "0.449",
    "BookValue": "4.535",
    "DividendPerShare": "6.13",
    "DividendYield": "0.0327",
    "EPS": "3",
    "RevenuePerShareTTM": "31.12",
    "ProfitMargin": "0.0971",
    "OperatingMarginTTM": "0.351",
    "ReturnOnAssetsTTM": "0.0771",
    "ReturnOnEquityTTM": "0.562",
    "RevenueTTM": "54999998000",
    "GrossProfitTTM": "41527000000",
    "DilutedEPSTTM": "3",
    "QuarterlyEarningsGrowthYOY": "-0.324",
    "QuarterlyRevenueGrowthYOY": "0.043",
    "AnalystTargetPrice": "195.08",
    "AnalystRatingStrongBuy": "4",
    "AnalystRatingBuy": "17",
    "AnalystRatingHold": "9",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "63.24",
    "ForwardPE": "14.58",
    "PriceToSalesRatioTTM": "5.29",
    "PriceToBookRatio": "27.74",
    "EVToRevenue": "6.15",
    "EVToEBITDA": "19.45",
    "Beta": "0.623",
    "52WeekHigh": "193.91",
    "52WeekLow": "132.11",
    "50DayMovingAverage": "169.39",
    "200DayMovingAverage": "163.26",
    "SharesOutstanding": "1765870000",
    "DividendDate": "2024-08-15",
    "ExDividendDate": "2024-07-15"
}